Inventor · disambiguated record
Alexander Beliaev
Also filed as: BELIAEV ALEXANDER · BELIAEV ALEXANDER S
15 granted patents·15 pending applications·18 citations·filing 2003–2024
87Inventor score
Files withBIAL PORTELA & CA SA12BELIAEV ALEXANDER4BIAL - PORTELA & CA S A3BIAL PORTELA & Cª S A2LEARMONTH DAVID ALEXANDER2
Top patents by PatentIndex Score
30 records- 0182US7259271B2Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparationPORTELA & CA SA·Filed 2006·Granted Aug 21, 2007·3 cites·12 claims
- 0280US8481582B21,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylaseSOARES DA SILVA PATRICIO MANUEL VIEIRA ARAUJO·Filed 2008·Granted Jul 9, 2013·3 cites·9 claims
- 0377US7125904B2Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparationPORTELA & CA SA·Filed 2003·Granted Oct 24, 2006·9 cites·19 claims
- 0474US2021261533A11,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylaseBIAL PORTELA & CA SA·Filed 2021·Application pending·0 cites
- 0573US9630951B21,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylaseBIAL-PORTELA & CA S A·Filed 2013·Granted Apr 25, 2017·1 cites·14 claims
- 0666US2024392332A1Cell Free-Based Biocatalyst for Formate Conversion into Value-Added ChemicalsGEORGIA TECH RES INST·Filed 2024·Application pending·0 cites
- 0766US2022017523A1BLOOD-BRAIN BARRIER-PENETRANT DOPAMINE-ß-HYDROXYLASE INHIBITORSBIAL PORTELA & CA SA·Filed 2021·Application pending·0 cites
- 0865US9353082B2Pharmaceutical compoundsKISS LASZLO ERNO·Filed 2009·Granted May 31, 2016·2 cites·64 claims
- 0964US2019322648A11,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylaseBIAL PORTELA & CA SA·Filed 2019·Application pending·0 cites
- 1064US2023138795A1Dopamine-b-hydroxylase inhibitorsBIAL PORTELA & CA SA·Filed 2022·Application pending·0 cites
- 1160US11034695B2Dopamine-β-hydroxylase inhibitorsBIAL—PORTELA & CA S A·Filed 2017·Granted Jun 15, 2021·0 cites·25 claims
- 1259US10975083B2Blood-brain barrier-penetrant dopamine-β-hydroxylase inhibitorsBIAL—PORTELA & Cᵃ S A·Filed 2017·Granted Apr 13, 2021·0 cites·21 claims
- 1358US2017369478A11,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylaseBIAL - PORTELA & CA S A·Filed 2017·Application pending·0 cites
- 1456US8158666B2Process for the preparation of (R)-5-(2-aminoethyl)-1-(6,8-difluorochroman-3-YL)-1,3-dihydroimidazole-2-thioneSOARES DA SILVA PATRICIO MANUEL VIEIRA ARAUJO·Filed 2008·Granted Apr 17, 2012·0 cites·16 claims
- 1555US9346751B2Process for preparing 1, 3-Dihydroimidazole-2-Thione DerivativesBELIAEV ALEXANDER·Filed 2012·Granted May 24, 2016·0 cites·20 claims
- 1654US11434242B2Dopamine-b-hydroxylase inhibitorsBIAL PORTELA & Cª S A·Filed 2018·Granted Sep 6, 2022·0 cites·14 claims
- 1754US8710239B2Process for preparing synthetic intermediates of peripherally-selective inhibitors of dopamine-β-hydroxylase involving catalytic asymmetric hydrogenationBELIAEV ALEXANDER·Filed 2009·Granted Apr 29, 2014·0 cites·21 claims
- 1852US2010217009A1Process for Preparing Chroman DerivativesBIAL PORTELA & CA SA·Filed 2008·Application pending·0 cites
- 1951US2010113799A1Process for the Preparation of (R) - 5 - (2-Aminoethyl) -1- (6, 8-Difluorochroman-3-YL) -1,3-Dihydroimidazole-2-ThioneBIAL PORTELA & CA SA·Filed 2008·Application pending·0 cites
- 2050US8957222B2Process for preparing intermediates of peripherally-selective inhibitors of dopamine-β-hydroxylase involving catalytic asymmetric hydrogenationBELIAEV ALEXANDER·Filed 2009·Granted Feb 17, 2015·0 cites·32 claims
- 2150US2011166360A1Catalytic Process for Asymmetric HydrogenationBIAL PORTELA & CA SA·Filed 2009·Application pending·0 cites
- 2249US8546571B2Catalytic hydrogenation of ene-carbamatesLEARMONTH DAVID ALEXANDER·Filed 2007·Granted Oct 1, 2013·0 cites·52 claims
- 2349US2010113550A1New Crystal FormsBIAL PORTELA AND CA S A·Filed 2007·Application pending·0 cites
- 2448US8865913B2Crystalline forms and processes for their preparationBIAL PORTELA & CA SA·Filed 2013·Granted Oct 21, 2014·0 cites·14 claims
- 2548US2010093817A1CompoundsBIAL PORTELA & CA SA·Filed 2008·Application pending·0 cites
- 2647US10059696B2Process for preparing 1,3-dihydroimidazole-2-thione derivativesBIAL PORTELA & CA SA·Filed 2016·Granted Aug 28, 2018·0 cites·19 claims
- 2745US2011053997A1Salts and Crystal FormsBELIAEV ALEXANDER·Filed 2008·Application pending·0 cites
- 2845US2009221656A1Drug CombinationsLEARMONTH DAVID ALEXANDER·Filed 2007·Application pending·0 cites
- 2945US2010298580A1Process for the Preparation of 2H-Chromene-3-Carbamate DerivativesBIAL PORTELA & CA SA·Filed 2008·Application pending·0 cites
- 3044US2022267331A1Dopamine-b-hydroxylase inhibitorsBIAL PORTELA & CA SA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alexander Beliaev files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →